Acquired Storage Pool Disease in Myeloproliferative Disorders

Authors:

Abstract
Defective aggregation and morphological abnormalities of platelets have been observed in myeloproliferative disorders, but their underlying nature is not well understood. We have examined 40 patients, 21 with thrombocythemia. 14 with polycythemia vera and 5 with myelofibrosis. All showed abnormal aggregation with ADP, adrenaline or collagen, and reduced content of platelet serotonin (5HT). ADP levels were also low, and ATP/ADP ratios correspondingly higher than normal. 5HT uptake was abnormal, and in the presence of imipramine, 14C-5HT leaked out of platelets during prolonged incubation in vitro, indicating a defect of the 5HT storage mechanism. Thromboxane B2, measured bv radio immunoassay, was produced in normal amounts when the platelets were challenged with thrombin. 5 U/ml, indicating that the prostaglandin synthesis pathway was unimpaired. The content of α-granule markers, suchas β-thromboglobulin and lysosomal enzyms, was normal in all patients, In essential thrombocythemia. polycythemia vera and in myelofibrosis, the platelet abnormality appears to be associated with an acquired defect of the storage mechanism for nucleotides and serotonin, affecting only some of the platelets. Whether this is due to the production of platelets by an abnormal stem cell line, or to exposure of platelets to inducers of the release reaction in vivo remains to be determined.